<DOC>
	<DOCNO>NCT00003120</DOCNO>
	<brief_summary>RATIONALE : Drugs use chemotherapy use different way stop cancer cell divide stop grow die . It yet know whether give paclitaxel short period time effective standard course treatment advanced ovarian cancer . PURPOSE : Randomized phase III trial compare effectiveness paclitaxel give 3 month paclitaxel give 12 month treat patient stage III stage IV ovarian , fallopian tube , primary peritoneal cancer .</brief_summary>
	<brief_title>S9701 Paclitaxel Treating Patients With Advanced Ovarian , Fallopian Tube , Primary Peritoneal Cancer Remission</brief_title>
	<detailed_description>OBJECTIVES : I . Compare effect continue paclitaxel 12 month versus 3 month progression free survival overall survival woman advance ovarian , fallopian tube , peritoneal cancer attain complete remission initial platinum ( carboplatin cisplatin ) paclitaxel base chemotherapy . II . Assess toxic effect associate prolonged paclitaxel administration patient . OUTLINE : This randomize study . Patients stratified stage ( optimal stage III vs suboptimal stage III v stage IV ) , prior treatment paclitaxel ( least 24 hour vs less 24 hour ) , age ( 65 vs 65 ) . Patients randomize one two treatment arm . Arm I : Patients receive paclitaxel IV 3 hour day 1 . Treatment continue every 4 week 3 course absence disease progression unacceptable toxicity . Arm II : Patients receive paclitaxel IV 3 hour day 1 . Treatment continue every 4 week 12 course absence disease progression unacceptable toxicity . Patients follow every 3 month disease progression 1 year registration , every 6 month 2 year , annually thereafter . PROJECTED ACCRUAL : A total 450 patient ( 225 per arm ) accrue study within 5 year .</detailed_description>
	<mesh_term>Ovarian Neoplasms</mesh_term>
	<mesh_term>Fallopian Tube Neoplasms</mesh_term>
	<mesh_term>Peritoneal Neoplasms</mesh_term>
	<mesh_term>Paclitaxel</mesh_term>
	<mesh_term>Albumin-Bound Paclitaxel</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically confirm advanced ovarian epithelial , fallopian tube , primary peritoneal cancer Must undergone initial exploratory laparotomy tumor debulking AND Must FIGO stage IIIA , IIIB , IIIC , IV time initial laparotomy Must attain clinically defined complete remission ( CR ) follow treatment platinum ( cisplatin carboplatin ) paclitaxel base combination chemotherapy regimen achieve follow : No evidence cancer physical examination CA125 great 35 units/mL Creatinine great 2.0 mg/dL OR Creatinine clearance great 60 mL/min Bilirubin great 2.0 mg/dL Negative ascites No evidence residual cancer CT scan abdomen/pelvis chest xray ( chest CT scan , perform ) No symptom felt secondary persistent malignancy Must receive minimum 5 maximum 6 course chemotherapy prior study Must register study within 21 56 day prior chemotherapy Not concurrently register SWOGS9618 , SWOGS9619 , SWOGS9912 , SWOGS0009 front line treatment phase III GOG trial PATIENT CHARACTERISTICS : Age : Any age Performance status : SWOG 02 Life expectancy : Not specify Hematopoietic : Granulocyte count least 1,200/mm3 Platelet count least 100,000/mm3 Hepatic : See Disease Characteristics Renal : See Disease Characteristics Other : No prior malignancy within past 5 year except adequately treat basal cell squamous cell skin cancer , carcinoma situ cervix , incidental carcinoid PRIOR CONCURRENT THERAPY : Biologic therapy : No concurrent antitumor treatment No concurrent immunotherapy Chemotherapy : See Disease Characteristics Recovered prior chemotherapy Prior cisplatin allow initial dose least 50 mg/m2 Prior carboplatin allow initial dose least 300 mg/m2 AUC least 4 No concurrent chemotherapy Endocrine therapy : No concurrent hormonal therapy Radiotherapy : No concurrent radiotherapy No prior abdominal/pelvic irradiation Surgery : See Disease Characteristics No second look laparotomy laparoscopy</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2014</verification_date>
	<keyword>stage III ovarian epithelial cancer</keyword>
	<keyword>stage IV ovarian epithelial cancer</keyword>
	<keyword>recurrent ovarian epithelial cancer</keyword>
	<keyword>fallopian tube cancer</keyword>
	<keyword>peritoneal cavity cancer</keyword>
</DOC>